Enjoy 10% Off All Products! Proudly Made in USA. Shop Now!

Enjoy 10% Off All Products! Proudly Made in USA. Shop Now!

Enjoy 10% Off All Products! Proudly Made in USA. Shop Now!

FINDING THE RIGHT CRO: KEY TO SUCCESS

Cracking the Code to SBIR/NIH/NIAID/BARDA Grants: Your Secret Weapon? 
A Reliable, One-Stop Preclinical CRO

  • By IBT Bioservices
  • 10 mins read

Securing non-dilutive funding through prestigious programs like SBIR, STTR, NIH/NIAID grants and through contract mechanisms with agencies like DOD and BARDA is a monumental achievement for anyone developing innovative vaccines or modern therapeutics. These grants represent a crucial lifeline, providing the financial backing needed to propel groundbreaking research forward. However, the application process is highly competitive and demands a meticulously crafted proposal that demonstrates not only scientific merit but also a clear and feasible path to preclinical validation.

This is where identifying a reliable, one-stop preclinical Contract Research Organization (CRO) becomes a key differentiator and a significant factor in your grant success. Establishing such a partner not only offers logistical advantage, but it’s a strategic move that significantly strengthens your proposal by giving the reviewer confidence in your ability to execute the proposed plan within your timeline and budget.

IBT Bioservices has supported a number of companies, institutes, and individuals by providing technical insights to optimize research plans, cost estimates / letters of support for associated studies as well as timelines for critical milestones. Our tailored approach has allowed multiple clients to secure non-dilutive funding and federal grants, cumulatively totaling over $150M. Our team at IBT has supported 120+ clients to optimize grant applications for early-stage development by providing scientific advice, drafting study plans and providing cost estimates along with a letter of support.

Cracking the Code to Government Funding?

A robust preclinical strategy, clearly articulated and backed by a credible partner, strengthens an application immeasurably. Here’s how IBT can help you navigate complex grant landscapes and improve your application’s success:

Demonstrating a Clear and Feasible Preclinical Plan

  • Grant reviewers want to see a well-thought-out and achievable preclinical development plan.
  • Partnering with a pre-clinical CRO that offers both in vitro and in vivo services allows you to present a seamless and integrated approach to your feasibility studies.
  • You can clearly outline the progression from initial laboratory testing to animal model studies, demonstrating a logical and efficient pathway for evaluating the safety and efficacy of your vaccine or therapeutic.
  • This clarity and feasibility significantly boost the confidence of grant reviewers.

Access to experts with impeccable record in winning NIH grants

  • Our team of scientists and management professionals brings over 15 years of hands-on experience in writing and securing NIH grants.
  • Collectively, our leadership has a proven track record of obtaining more than $100 million in NIH and DoD funding.
  • This depth of experience significantly enhances your chances of success.

Accessing Specialized Expertise and Resources – Instant Credibility

  • Your grant proposal needs to showcase that you have the necessary expertise and resources to execute your preclinical plan effectively.
  • By partnering with a reputable CRO like IBT that specializes in preclinical research for your specific therapeutic area (e.g., virology, bacteriology, immunology), you instantly gain access to their experienced scientists, state-of-the-art facilities, validated assays, and established animal models.
  • Mentioning a collaboration with a well-regarded CRO in your proposals adds significant credibility and also helps justify your budget.

Strengthening the Commercialization Plan

  • Many of these grants, especially SBIR, NIH contracts, and BARDA, heavily emphasize the commercialization potential of your innovation.
  • A clear and robust preclinical plan, supported by a credible CRO partner, directly addresses this criterion.
  • It shows reviewers that you are not just conducting basic research but are actively taking steps towards developing a viable product.
  • Our team at IBT has the required experience and can help you design studies that generate data relevant for future regulatory submissions, further strengthening your commercialization narrative.

Streamlining Budget and Timeline Justification

  • Partnering with a CRO early in the process allows you to obtain accurate cost estimates for your preclinical studies and design phase-appropriate studies, ensuring a realistic and well-supported budget proposal.
  • IBT can provide realistic timelines for each stage of preclinical testing, demonstrating that your project is well-planned and achievable within the grant’s timeframe.
  • In short, we will simplify this process by providing a comprehensive budget and timeline for the entire preclinical phase.

Reducing Risk and Enhancing Project Management

  • Grant funding is often milestone-driven.
  • Demonstrating a proactive approach to risk mitigation and efficient project management is crucial.
  • With our extensive experience in the preclinical space, we can offer valuable support to our clients as they navigate the complexities of grant applications to fund preclinical research.
  • IBT’s expertise in study design, execution, data analysis, and reporting minimizes potential pitfalls and ensures that projects stay on track, increasing the chances of meeting grant milestones and securing further funding.
  • We simplify project management by centralizing communication and coordination.

Leveraging Specialized Assays and Models

  • Developing vaccines and therapeutics often requires specialized in vitro and in vivo assays and disease models.
  • A CRO like IBT Bioservices, with its deep expertise in areas like virology, bacteriology, and immunology, offers access to cutting-edge assays (e.g., Neutralization Assays, PRNT, ELISPOT, ELISA, Luminex) and relevant animal models that are critical for evaluating the efficacy and safety of your specific intervention.
  • Highlighting access to these specialized capabilities in your grant proposal demonstrates a sophisticated understanding of your preclinical needs.

Building a Strong Foundation for Future Funding

  • Successful completion of preclinical studies is a crucial step toward securing further funding, whether through follow-on grants or private investment. High-quality data generated by a reputable CRO strengthens your overall development package and increases investor confidence.
  • IBT can also support IND-enabling studies and GxP-compliant testing with phase-appropriate compliance levels.
  • We’re not just your preclinical partner; we’re your strategic ally, ensuring you’re well-positioned to secure future funding long after this initial phase!

In summary, navigating the competitive landscape of SBIR, NIH, NIAID, BARDA or any other Funding Opportunity Announcements (FOA) requires a compelling scientific rationale coupled with a clear and credible preclinical development plan. Identifying a reliable, one-stop preclinical CRO like IBT Bioservices early in the application process is not just a logistical advantage; it’s a strategic move that significantly strengthens your proposal development.

Chat with our team?

Contact us today to learn how we can support your next grant application.

need a referral?

Our existing partners love boasting about our collaborations! We are happy to provide referrals if needed.

Tell Us About Your Enquiry

    Share This

    Facebook
    Twitter
    LinkedIn

    CATEGORIES

    RECENT POSTS

    Finding the right CRO for grants

    Read More

    Staphylococcus aureus bacteremia Non-Human Primate model

    Read More

    Your Ultimate Guide: Our Upgraded Webstore’s New Features Make Shopping Easy!

    Read More

    SUBSCRIBE HERE!

    Subscribe to the IBT Bioservices Tech Talk list and receive periodic updates on industry news and IBT Bioservices products and services.

    CLICK TO SUBSCRIBE

    You may also like

    Sign up for our newsletter
    Linkedin Instagram Youtube

    Copyright © 2023. All rights reserved by Stratedgy.

    Contact Us

    For Product Information,
    Orders & Technical Support

    products@integratedbiotherapeutics.com

    For Services
    services@ibtbioservices.com

    Company

    Media

    Services By Disease Target

    Search
    Generic filters